These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11300331)

  • 1. Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
    Cascinu S; Graziano F; Valentini M; Catalano V; Giordani P; Staccioli MP; Rossi C; Baldelli AM; Grianti C; Muretto P; Catalano G
    Ann Oncol; 2001 Feb; 12(2):239-44. PubMed ID: 11300331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
    Tsujitani S; Konishi I; Suzuki K; Oka S; Gomyo Y; Matsumoto S; Hirooka Y; Kaibara N
    J Exp Clin Cancer Res; 2000 Jun; 19(2):189-95. PubMed ID: 10965817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.
    Kornmann M; Link KH; Galuba I; Ott K; Schwabe W; Häusler P; Scholz P; Sträter J; Polat S; Leibl B; Kettner E; Schlichting C; Baumann W; Schramm H; Hecker U; Ridwelski K; Vogt JH; Zerbian KU; Schütze F; Kreuser ED; Behnke D; Beger HG
    J Gastrointest Surg; 2002; 6(3):331-7. PubMed ID: 12022983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
    Trocha SD; Saha SS; Wiese D; Thompson J; Morton DL; Bilchik AJ
    Am Surg; 2003 Oct; 69(10):918-22. PubMed ID: 14570375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method.
    Takenoue T; Nagawa H; Matsuda K; Fujii S; Nita ME; Hatano K; Kitayama J; Tsuruo T; Muto T
    Ann Surg Oncol; 2000 Apr; 7(3):193-8. PubMed ID: 10791849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
    Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
    J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.
    Cascinu S; Graziano F; Catalano V; Staccioli MP; Rossi MC; Baldelli AM; Barni S; Brenna A; Secondino S; Muretto P; Catalano G
    Br J Cancer; 2002 Mar; 86(5):744-9. PubMed ID: 11875737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
    Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
    Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
    Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
    Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?
    Prall F; Ostwald C; Schiffmann L; Barten M
    Oncol Rep; 2007 Jul; 18(1):203-9. PubMed ID: 17549369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
    Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
    Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
    Jensen SA; Vainer B; Sørensen JB
    Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.
    Hua D; Huang ZH; Mao Y; Deng JZ
    World J Gastroenterol; 2007 Oct; 13(37):5030-4. PubMed ID: 17854149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.